+987.9%
MRNA vs FE
+6.1%
+981.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | 0.0% | +13.1% | +13.1% |
| 7D | +20.6% | +1.7% | +19.0% | +20.8% |
| 30D | +27.1% | +8.1% | +19.0% | +27.1% |
| 3M | +353.4% | -1.3% | +354.7% | +357.3% |
| 6M | +446.3% | +2.9% | +443.4% | +447.0% |
| YTD | +776.2% | +8.6% | +767.6% | +725.7% |
| 1Y | +987.9% | +6.3% | +981.6% | +959.4% |
| All | +987.9% | +6.1% | +981.8% | +959.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FE.
Daily Out/Under-Performance
Portfolio return minus FE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling